Clinical Trial

A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets

Name: A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets — clinical trial record (NCT07639905)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a single-center, single-dose, randomized, open-label, two-period, crossover phase I clinical trial, comparing the bioavailability and safety of the new and old processes of HRS-2189 tablets in healthy subjects.

Trial Details

NCT Number	NCT07639905
Lead Sponsor	Shandong Suncadia Medicine Co., Ltd.
Conditions	Malignant Solid Tumor
Enrollment	28 participants
Start Date	2026-06
Primary Completion	2026-07 (estimated)
Study Completion	2026-07 (estimated)
Updated on ClinicalTrials.gov	2026-06-10